Skip to main content
Search

Merck & Co., Inc., Rahway, NJ, USA (United States)

2 related articles

Subscribe to updates
  1. Peptide design spaces pass 1050: a linear model plus dynamic programming returns the global optimum

    Noncanonical amino acids push peptide design spaces to the 1050 scale, where exhaustive screening is infeasible. PepOpt encodes each residue as a position-specific molecular fingerprint, predicts potency with linear regression, and uses dynamic programming under an additivity assumption to find the globally optimal sequence deterministically. Across 11 internal peptide series it matches or beats nonlinear models, and in 1020 and 1050 spaces it returns higher predicted scores than a genetic algorithm.

  2. arXiv

    In multi-agent hypothesis generation, the first self-critique round adds 34.5 pp of mechanism divergence while the equivalence rule itself shapes measured diversity

    In a multi-agent hypothesis-generation workflow, the authors held opening hypotheses fixed and replayed downstream stages, using an LLM-as-a-judge to decide whether paired hypotheses describe the same mechanism: moving from 0 to 1 self-critique round produced 34.5 percentage points of extra mechanism-level divergence while 1 to 5 rounds added 1.3 pp; under controlled perturbations all three equivalence rules were invariant to meaning-preserving edits, but when the initiating event was replaced the LLM-as-a-judge read 83% of pairs as different mechanisms versus 0% for TF-IDF and 8% for embeddings, and changing only the rubric moved this rate from 38% to 96%.

You’re all caught up